1009-9921
2013 Issue 2
Successful treatment of B cell prolymphocytic leukemia by fludarabine, cyclophosphomide and rituximab therapy: own experience and literature review
ZHANG Yan-ru;LI Zeng-jun;QI Jun-yuan;QIU Lu-gui
ZHANG Yan-ru;LI Zeng-jun;QI Jun-yuan;QIU Lu-gui
..............page:91-93,97
Preliminary study on IL-7Rα intervening acute graft-versus-host disease after mice allogeneic bone marrow transplantation
WEI Fen;MA Liang-ming;GONG Xu-dong;REN Lian-sheng;ZHU Lei;GUO Hui-min;ZHANG Hua-ping
WEI Fen;MA Liang-ming;GONG Xu-dong;REN Lian-sheng;ZHU Lei;GUO Hui-min;ZHANG Hua-ping
..............page:115-118
smile fang an zhi liao qin xi xing nk xi bao bai xue bing ji jie wai nk/t xi bao bai xue bing er li
tian chen ; wang ya fei ; yu yong ; zhang yi zuo ; zhang ling
tian chen ; wang ya fei ; yu yong ; zhang yi zuo ; zhang ling
..............page:119-120
Chromosome karyotype analysis of acute lymphocytic leukemia
LI Qian-yu;WEI Xu-dong;HU Jie-ying;MI rui-hua
LI Qian-yu;WEI Xu-dong;HU Jie-ying;MI rui-hua
..............page:88-90
fei huo qi jin lin ba liu he bing ji xing sui xi bai xue bing yi li
gu lei ; liang wen tong ; cheng zhi yong ; liu zhan wu ; zhang peng ju ; meng zhao qiang
gu lei ; liang wen tong ; cheng zhi yong ; liu zhan wu ; zhang peng ju ; meng zhao qiang
..............page:127-128
Evolution, differential diagnosis and intervention strategies of monoclonal gammopathy of undetermined significances:reports in the 54 ASH annual meeting
LI Jian-ping;FENG Jian-ming
LI Jian-ping;FENG Jian-ming
..............page:74-76,80
Clinical analysis of chemotheray-induced lung injury in 26 patients with malignant hematological diseases
ZHAO Wei;DONG Fei;WANG Jing;KE Xiao-yan
ZHAO Wei;DONG Fei;WANG Jing;KE Xiao-yan
..............page:94-97
..............page:85-87
Report on one case of IgG4-related retroperitoneal fibrosis and literatures review for IgG4-related disease
NIU Qiang;DING Qian-qian;CHEN Qin-fen
NIU Qiang;DING Qian-qian;CHEN Qin-fen
..............page:101-104
Report on recent progress of multiple myeloma in the 54th ASH annual meeting
ZHANG Chun-yang;HOU Jian
ZHANG Chun-yang;HOU Jian
..............page:67-70
Phase Ⅱ clinical trail of patients with relapsed follicular lymphoma treated with a humanized anti-programmed death-1 monoclonal antibody combined with rituximab:report in the 54th ASH annual meeting
CHU Fu-liang;Westin JR;ZHANG Ming;JING Yu;LI Ya-fen;TANG Jin-le;ZONG Yun-hui;LIU Bin;Davis RE;Neelapu SS;YANG Lin
CHU Fu-liang;Westin JR;ZHANG Ming;JING Yu;LI Ya-fen;TANG Jin-le;ZONG Yun-hui;LIU Bin;Davis RE;Neelapu SS;YANG Lin
..............page:77-80
Cladribine for treatment on hairy cell leukemia: three cases report and literatures review
YANG Wen-juan;LI Zeng-jun;QI Jun-yuan;LIU Wei;XU Yan;ZHAO Yao-zhong;QIU Lu-gui
YANG Wen-juan;LI Zeng-jun;QI Jun-yuan;LIU Wei;XU Yan;ZHAO Yao-zhong;QIU Lu-gui
..............page:98-100
Expression of WT1 gene in acute leukemia and its clinical significance
ZHAO Wan-hong;MENG Shan;MENG Xin;CAO Xing-mei;CHEN Yin-xia;HE Ai-li;LIU Jie;MA Xiao-rong;ZHANG Wang-gang
ZHAO Wan-hong;MENG Shan;MENG Xin;CAO Xing-mei;CHEN Yin-xia;HE Ai-li;LIU Jie;MA Xiao-rong;ZHANG Wang-gang
..............page:107-110
yi qu kang zuo zhi liao zi ti zao xue gan xi bao yi zhi bing fa qin xi xing zhen jun bing yi li
huang chong lun ; song lu zuo
huang chong lun ; song lu zuo
..............page:126-127
Clinical observation of caffeic acid for the treatment of leukopenia and thrombocytopenia induced by imatinib in patients with chronic myeloid leukemia
GAN Si-lin;ZHOU Jian-wen;SUN Hui
GAN Si-lin;ZHOU Jian-wen;SUN Hui
..............page:105-106
Study progress of the stereotyped B-cell receptor in chronic lymphocytic leukemia: reports in the 54 ASH annual meeting
YU Zhen;QIU Lu-gui
YU Zhen;QIU Lu-gui
..............page:65-66,70
Highlights of the development in personalized treatment of patients with diffuse large B-cell lymphoma:reports in the 54 ASH annual meeting
LIU Yan-yan;LI Yu-fu;YANG Shu-jun;SONG Yong-ping
LIU Yan-yan;LI Yu-fu;YANG Shu-jun;SONG Yong-ping
..............page:71-73
Study progress of relationship between systemic lupus erythematosus and hematological malignancies
FANG Zhen-yu
FANG Zhen-yu
..............page:124-125,128
Circadian rhythms and hematopoietic tumors
WU Ke-fu;MA Xiao-tong;ZHENG Guo-guang;SONG Yu-hua
WU Ke-fu;MA Xiao-tong;ZHENG Guo-guang;SONG Yu-hua
..............page:81-84
..............page:84,90,104,110,前插1
Comparison analysis of cellular morphology and immune phenotypic in Uygur and Han patients with myelodysplastic syndrome
ZHU Lin;AN Li;REN Xue-rui;WANG Xiao-min
ZHU Lin;AN Li;REN Xue-rui;WANG Xiao-min
..............page:111-114
ru xian ai hua liao hou ji fa ji xing zao you li xi bao bai xue bing er li bing wen xian fu xi
duan yan chao ; zhang zhi
duan yan chao ; zhang zhi
..............page:122-123
de bakey xing zhu dong mai jia ceng he bing ji xing bai xue bing yi li bing wen xian fu xi
wang zhan ying ; zhang yan ling ; guo hong gang
wang zhan ying ; zhang yan ling ; guo hong gang
..............page:121-122